期刊文献+

miR-155下调Ets-1参与溃疡性结肠炎的发病机制 被引量:7

The Role of miR-155 in Pathogenesis of Ulcerative Colitis in Mice by Down-regulating Ets-1
原文传递
导出
摘要 目的探讨miR-155在溃疡性结肠炎(UC)中的作用机制。方法构建miR-155高表达溃疡性结肠炎小鼠模型,并进一步采用Western blot方法检测外周血白细胞转录调节因子-1(EST-1)及Th17相关炎症因子蛋白表达。结果在UC模型组,miR-155基因转染后小鼠外周血白细胞中miR-155表达量较对照显著升高,且与UC结肠炎症程度呈正相关;UC模型组小鼠外周血白细胞中Est-1呈低表达,而Th17相关细胞因子(IL-17、IL-23及IL-6)呈相对高表达;miR-155转染后,UC小鼠这种变化趋势更加显著,Est-1表达更低,而IL-17、IL-23及IL-6表达更高。结论 miR-155通过抑制Ets-1表达,进而促进Th17相关炎症因子分泌参与溃疡性结肠炎的发病。 Objective To investigate the role of miR-155 in mice with ulcerative colitis(UC). Methods The ulcerative colitis mice model with miR-155 high expression was established,E 26 transformation specific-1(Ets-1)and T helper 17 cells(Th17)associated cytokines expression was tested with Western blotting method. Results In UC mice group, the miR-155 expression in peripheral white blood cell(WBC) was significant higher after gene transfection and was positively associated with the severity of colitis. Est-1 in peripheral WBC was lowly expressed in UC mice,while Th17 associated cytokines IL-17,IL-23 and IL-6 were relatively highly expressed. After miR-155 gene transfection,the trend of lower expression of Est-1 and higher expression of IL-17、IL-23 and IL-6 was more obvious. Conclusion miR-155 is involved in the pathogenesis of UC by inhibiting Ets-1 expression, and further promoting Th17 associated inflammation cytokine excretion.
出处 《中药新药与临床药理》 CAS CSCD 北大核心 2015年第3期307-310,共4页 Traditional Chinese Drug Research and Clinical Pharmacology
基金 广东省科技计划项目(2012B031800483)
关键词 溃疡性结肠炎 MIR-155 Est-1 辅助性T细胞17 Ulcerative colitis miR-155 Est-1 T helper 17 cell
  • 相关文献

参考文献15

  • 1Pekow JR, Kwon JH. MicroRNAs in infla mmatory bowel disease[J]. Inflamm Bowel Dis, 2012, 18(1): 187-193.
  • 2周鹏志,刘凤斌,罗琦,孙嫣,丁飞跃,陈斌.白头翁汤对溃疡性结肠炎小鼠肠道miR-19a表达的影响[J].南方医科大学学报,2012,32(11):1597-1599. 被引量:16
  • 3周鹏志,陈斌,胡品津,孙嫣.miR-19a对溃疡性结肠炎的作用机制[J].南方医科大学学报,2013,33(9):1325-1328. 被引量:5
  • 4Romania P, Lulli V, Pelosi E, et al. MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meisl transcription factors [J]. Br J HaemaM, 2008, 143 (4) :570-580.
  • 5Murano M, Maemura K, Hirata I, et al. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium(DSS)-induced colitis [J]. Clin Exp Immunol, 2000, 120(1): 51-58.
  • 6Kluiver J, van den Berg A, de Jong D, et al. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma[J]. Oncogene, 2007, 26(26): 3769-3776.
  • 7Bluml S, Bonelli M, Niederreiter B, et al. Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice[J]. Arthritis Rheum, 2011, 63(5): 1281-1258.
  • 8Murugaiyan G, Beynon V, Mittal A, et al. Silencing mieroRNA-155 ameliorates experimental autoimmune encephalomyelitis[J]. J Immunol, 2011, 187(5): 2213-2221.
  • 9Romania P, Lul|i V, Pelosi E, megakaryopoiesis at progenitor and and Meisl transcription factors[J]. 570-580. et al. MicroRNA 155 modulates precursor level by targeting Ets-1 Br J Haematol, 2008, 143(4):.
  • 10] Wen Z, Xu L, Chen X, et al. Autoantibody induction by DNA- containing immune complexes requires HMGB1 with the TLR2/ microRNA-155 pathway[J]. J Immunol, 2013, 190( 11 ) : 5411-5422.

二级参考文献18

  • 1汪远平.白头翁汤治疗溃疡性结肠炎48例[J].实用中医内科杂志,2007,21(5):49-49. 被引量:28
  • 2Iborra M, Bemuzzi F, lnvemizzi P, et al. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response[J]. Autoimmun Rev, 2012, 11(5): 305-14.
  • 3Wu F, Guo N J, Tian H, et al. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease[J]. Inflamm Bowel Dis, 2011, 17( 1 ): 241-50.
  • 4Pekow JR, Kwon JH, MicroRNAs in inflammatory bowel disease [J]. Inflamm Bowel Dis, 2012, 18(1): 187-93.
  • 5Dalai SR, Kwon JH. The role of microRNA in inflammatory bowel disease[J]. Gastroenterol Hepatol (NY), 2010, 6(11): 714-22.
  • 6Takagi T, Naito Y, Mizushima K, et al. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis [J]. J Gastroenterol Hepatol, 2010, 25 Suppl 1: S129-33.
  • 7Duttagupta R, DiRienzo S, Jiang R, et al. Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis [J]. PLOS ONE, 2012, 7(2): e31241.
  • 8Bian Z, Li L, Cui J, et al. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis [J]. J Pathol, 2011,225(4): 544-53.
  • 9Ota A, Tagawa H, Karnan S, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma[J]. Cancer Res, 2004, 64(9): 3087-95.
  • 10Pezzolesi MG, Platzer E Waite KA, et al. Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in cowden syndrome[J]. Am J Hum Genet, 2008, 82(5): 1141-9.

共引文献18

同被引文献56

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部